Axsome Therapeutics, Inc. (AXSM)
Company Info
| ISIN | US05464T1043 |
|---|---|
| CUSIP | 05464T104 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $3.40B |
|---|---|
| EPS | -$5.27 |
| Revenue (TTM) | $270.60M |
| Gross Profit (TTM) | $45.94M |
| EBITDA (TTM) | -$182.45M |
| Year Range | $55.02 - $98.40 |
| Target Price | $123.00 |
| Short % | 19.69% |
| Short Ratio | 11.26 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: AXSM vs. ARDX, AXSM vs. INZY, AXSM vs. SPY, AXSM vs. VOO, AXSM vs. AAPL, AXSM vs. NVO, AXSM vs. IWDA.L
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Axsome Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Axsome Therapeutics, Inc. had a return of -9.90% year-to-date (YTD) and 0.77% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -9.90% | 6.92% |
| 1 month | -9.42% | -2.83% |
| 6 months | 15.51% | 23.86% |
| 1 year | 0.77% | 23.33% |
| 5 years (annualized) | 32.39% | 11.66% |
| 10 years (annualized) | N/A | 10.52% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 13.12% | -9.61% | -1.94% | |||||||||
| 2023 | -13.50% | -10.89% | 8.30% | 18.00% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Axsome Therapeutics, Inc.(AXSM)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Axsome Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Axsome Therapeutics, Inc. was 86.65%, occurring on Dec 27, 2018. Recovery took 59 trading sessions.
The current Axsome Therapeutics, Inc. drawdown is 32.50%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -86.65% | Jan 6, 2016 | 750 | Dec 27, 2018 | 59 | Mar 25, 2019 | 809 |
| -81.26% | Dec 27, 2019 | 415 | Aug 19, 2021 | — | — | — |
| -42.7% | Sep 17, 2019 | 11 | Oct 1, 2019 | 35 | Nov 19, 2019 | 46 |
| -17.63% | Mar 26, 2019 | 14 | Apr 12, 2019 | 8 | Apr 25, 2019 | 22 |
| -17.48% | Jul 29, 2019 | 14 | Aug 15, 2019 | 21 | Sep 16, 2019 | 35 |
Volatility
Volatility Chart
The current Axsome Therapeutics, Inc. volatility is 11.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |